Work

The prolong trial: A two Phase randomized placebo-controlled trial to optimize rituximab response with dexamethasone and maintenance therapy with low dose rituximab in immune thrombocytopenia (ITP) patients

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-736

Authors: Waleed Ghanima, Doaa El Demerdash, Henrik Frederiksen, James Bussel, Galina Tsykunova, Marc Michel, Hoa Tran, Carina Nassar, Bernadette Darne, Eirik Tjønnfjord, Tor Henrik Tvedt, Fehmi M'Sadek, Mervat Mattar, Abderraheem Khelif, Pål Holme

Institutions: University of Oslo, Østfold Hospital Trust, Cairo University, Cairo University hospitals, University of Southern Denmark, Odense University Hospital, Cornell University, Centre Hospitalier Universitaire Henri-Mondor, Hôpitaux Universitaires Henri-Mondor, Monitoring Force Group (France), Oslo University Hospital, Military Hospital of Tunis, Hôpital Farhat Hached

Language: English

Topic: Platelet Disorders and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417004479

Cites:

Cited by:

Related to: